Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 4
2015 4
2016 1
2017 1
2018 1
2020 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Patterns of Temporal Lobe Reaction and Radiation Necrosis after Particle Radiotherapy in Patients with Skull Base Chordoma and Chondrosarcoma-A Single-Center Experience.
Mattke M, Ohlinger M, Bougatf N, Wolf R, Welzel T, Roeder F, Gerum S, Fussl C, Annon-Eberharter N, Ellerbrock M, Jäkel O, Haberer T, Herfarth K, Uhl M, Debus J, Seidensaal K, Harrabi S. Mattke M, et al. Among authors: fussl c. Cancers (Basel). 2024 Feb 8;16(4):718. doi: 10.3390/cancers16040718. Cancers (Basel). 2024. PMID: 38398109 Free PMC article.
First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure.
Roeder F, Fastner G, Fussl C, Sedlmayer F, Stana M, Berchtold J, Jäger T, Presl J, Schredl P, Emmanuel K, Colleselli D, Kotolacsi G, Scherer P, Steininger P, Gaisberger C. Roeder F, et al. Among authors: fussl c. Radiat Oncol. 2023 Nov 10;18(1):186. doi: 10.1186/s13014-023-02374-6. Radiat Oncol. 2023. PMID: 37950314 Free PMC article.
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G, Reitsamer R, Urbański B, Kopp P, Murawa D, Adamczyk B, Karzcewska A, Milecki P, Hager E, Reiland J, Ciabattoni A, Matuschek C, Budach W, Nowell K, Schumacher C, Ricke A, Fusco V, Vidali C, Alessandro M, Ivaldi GB, Ziegler I, Fussl C, Zehentmayr F, Grambozov B, Sir A, Hitzl W, Ricardi U, Sedlmayer F. Fastner G, et al. Among authors: fussl c. Radiother Oncol. 2020 May;146:136-142. doi: 10.1016/j.radonc.2020.02.001. Epub 2020 Mar 6. Radiother Oncol. 2020. PMID: 32151790 Clinical Trial.
Intraoperative radiotherapy (IORT) as boost in breast cancer.
Sedlmayer F, Reitsamer R, Wenz F, Sperk E, Fussl C, Kaiser J, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: fussl c. Radiat Oncol. 2017 Jan 19;12(1):23. doi: 10.1186/s13014-016-0749-9. Radiat Oncol. 2017. PMID: 28103903 Free PMC article. Review.
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr F, Söhn M, Exeli AK, Wurstbauer K, Tröller A, Deutschmann H, Fastner G, Fussl C, Steininger P, Kranzinger M, Belka C, Studnicka M, Sedlmayer F. Zehentmayr F, et al. Among authors: fussl c. Radiat Oncol. 2015 May 28;10:121. doi: 10.1186/s13014-015-0429-1. Radiat Oncol. 2015. PMID: 26018527 Free PMC article.
Boost IORT in Breast Cancer: Body of Evidence.
Sedlmayer F, Reitsamer R, Fussl C, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: fussl c. Int J Breast Cancer. 2014;2014:472516. doi: 10.1155/2014/472516. Epub 2014 Sep 2. Int J Breast Cancer. 2014. PMID: 25258684 Free PMC article. Review.
13 results